Search - tctmd.com

Displaying 1 - 20 of 128

Sort: Relevancy | Date

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

Caitlin E. Cox

January 30, 2024

News Conference News ISET 2024

Venous Stents: How to Choose Among the Wealth of Options

Caitlin E. Cox

January 26, 2024

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Daily News

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Caitlin E. Cox

December 30, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

Advertisement

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

Venous Stents: How to Choose Among the Wealth of Options

High-Sensitivity Troponins May Overestimate PE Severity

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

October 2023 News Roundup

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

PAD Significantly Ups Morbidity and Mortality in AMICS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content